Charles River Laboratories (CRL) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Charles River Laboratories (CRL) stock, a company in the Health Care (Life Sciences Tools & Services) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Charles River Laboratories at a glance

What you'll see in your CRL model

• 10 years of audited historical financials for Charles River Laboratories, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
• Triangulated Wall Street consensus for CRL's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
• AI Event Factors: top-10 news/social themes for CRL with probability sliders and live EPS impact.
• Sensitivity tables and Excel export for every assumption.

About Charles River Laboratories

Charles River Laboratories (NYSE/NASDAQ: CRL) was founded in 1947 and is headquartered in Wilmington, Massachusetts. The company operates in the Health Care sector (Life Sciences Tools & Services sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Charles River Laboratories in roughly five seconds and lets you adjust every assumption to test your own thesis.